References in periodicals archive ?
James Patterson, managing director of BP, said: "We are delighted to be partnering with CBio and NVM to create an enlarged business that will offer an extensive range of products and services to exploit the growing demand for biotechnology solutions for waste control and cleaning requirements."
Figura 3--Relacao percentual de docentes e discentes Participantes do I Workshop Relacao de docentes e discentes Docentes mediadores 13% Disc CC 13% Docentes presentes 48% Disc CBio 4% Discentes EP 22% Nota: Tabla derivada de grafico de segmentado
According to him, this agreement underscores the longstanding relationship between Ericsson and Zain, and following the successful implementation of CBIO solution in Zain Jordan.
Ericsson's CBIO solution will allow both prepaid and
16 December 2011 - Danish pharma major Novo Nordisk AS (CPH:NOVO B) has decided not to exercise its right to license autoimmune diseases drug candidate Xtoll, Australian early-stage drug development company CBio Ltd (ASX:CBZ) announced Thursday.
Cathay Industrial Biotech, which on Tuesday submitted documents with the US Securities and Exchange Commission (SEC) in connection with the IPO, intends to list on Nasdaq under the symbol "CBIO."
Australian drug development company CBio Limited (ASX:CBZ) today announced confirmation from the Japanese Patent Office that it intends to grant the "Chaperonin 10 Immunosuppression" patent.
They claim that, since leaving the EMA in December 2010, Lonngren has held the positions of strategic adviser for the NDA group and non-executive director for CBIO. "We wonder whether rules on conflicts of interests are being breached, in particular Title II of Article 16 (96) of the Rules for Servants of the European Communities," commented Lepage.
Attaining health for all through community partnerships: principles of the census-based, impactoriented (CBIO) approach to primary health care developed in Bolivia, South America.
The CBio from AWID of Monsey, New York, is a fingerprint verification reader that provides a standard Wiegand output of the cardholder number after accurate verification of the user's fingerprint.
(NASDAQ: CBIO), today announced an oral presentation at the Second Annual 2019 Hemophilia Drug Development (HDD) Summit being held from August 20-22, 2019 in Boston.
Catalyst Biosciences (CBIO) downgraded to Neutral from Buy at B.
Acronyms browser ?
Full browser ?